We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Sells Rights to Former Blockbuster Statin Drug Crestor for $320 Million
AstraZeneca Sells Rights to Former Blockbuster Statin Drug Crestor for $320 Million
AstraZeneca is selling off limited rights to its former blockbuster statin drug Crestor to Grünenthal for $320 million upfront and possible future milestone payments of up to $30 million.